Lataa...
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
In December 2019, COVID-19 epidemic was described in Wuhan, China, and the infection has spread widely affecting hundreds of thousands. Herein, an effort was made to identify commercially available drugs in order to repurpose them against coronavirus by the means of structure-based virtual screening...
Tallennettuna:
| Julkaisussa: | J Biomol Struct Dyn |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7189413/ https://ncbi.nlm.nih.gov/pubmed/32306862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1758791 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|